Myeongseob Lee

Myeongseob Lee

Auto-generated profile, based on publicly available information

Myeongseob Lee

Department of Pediatrics, Severance Children's Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in The Journal of Pediatrics
Verified
Journal Article
Closed access
KSKyungchul Song
Kyungchul Song
GPGoeun Park
Goeun Park
HLHye Sun Lee
Hye Sun Lee
MLMyeongseob Lee
Myeongseob Lee
HLHae In Lee
Hae In Lee
HCHyun Wook Chae
Hyun Wook Chae

29 April 2022 in Biology
Verified
Journal Article
Open access
PDF file
KSKyungchul Song
Kyungchul Song
HLHae Won Lee
Hae Won Lee
HCHan Saem Choi
Han Saem Choi
GPGoeun Park
Goeun Park
HLHye Sun Lee
Hye Sun Lee
HCHyun Wook Chae
Hyun Wook Chae
We investigated the modified triglycerides-glucose (TyG) indices and other markers for non-alcoholic fatty liver disease (NAFLD) in 225 participants aged 10–19 years, and the participants were divided into subgroups according to their NAFLD grade. We performed logistic regression analysis and calculated the odds ratios (ORs) with 95% confidence intervals (CIs) of tertiles 2 and 3 for each parameter, with those of tertile 1 as a reference. The area under the receiver operating characteristic (ROC) curve was calculated to compare the parameters for identifying NAFLD. TyG and modified indices, aspartate transaminase-to-platelet ratio index (APRI)-body mass index (BMI), APRI-BMI standard deviation score (SDS), APRI waist-to-hip ratio, fibrosis-4 index (FIB)-4, and hepatic steatosis index (HSI) were higher in participants with NAFLD than in those without NAFLD. The ORs and 95% CIs for NAFLD progressively increased across tertiles of each parameter. TyG and modified TyG indices, FIB-4, HSI, and modified APRIs, except APRI waist-to-height ratio, predicted NAFLD significantly through ROC curves. Modified TyG indices, APRI-BMI SDS, and HSI were superior to the other markers for NAFLD prediction. Modified TyG indices, APRI-BMI SDS, and HSI appear to be useful for assessing NAFLD in youths.

1 January 2023 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
KSKyungchul Song
Kyungchul Song
JYJuyeon Yang
Juyeon Yang
HLHye Sun Lee
Hye Sun Lee
SKSujin Kim
Sujin Kim
MLMyeongseob Lee
Myeongseob Lee
HCHyun Wook Chae
Hyun Wook Chae
Song K, et al. Yonsei Med J. 2023 Apr;64(4):269-277. https://doi.org/10.3349/ymj.2022.0540

2 March 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
KSKyungchul Song
Kyungchul Song
GPGoeun Park
Goeun Park
HLHye Sun Lee
Hye Sun Lee
MLMyeongseob Lee
Myeongseob Lee
HLHae In Lee
Hae In Lee
HCHyun Wook Chae
Hyun Wook Chae
Investigations on the trends of prediabetes and non-alcoholic fatty liver disease (NAFLD) among children are scarce. We aimed to analyze the trends of prediabetes and NAFLD, as well as their association, among Korean children and adolescents from 2009 to 2018. This study investigated the prevalence of prediabetes, NAFLD, and abdominal obesity among 6327 children and adolescents aged 10–18 years according to age, sex, and body mass index (BMI) using a nationally representative survey. The prevalence of prediabetes, NAFLD, and abdominal obesity increased from 5.14%, 8.17%, and 5.97% respectively, in 2009 to 10.46%, 12.05%, and 10.51% respectively, in 2018. In age-specific analyses, an adverse trend in NAFLD was significant only in participants aged 16–18 years while the prevalence of prediabetes worsened significantly in all age groups. In BMI-specific analyses, the prevalence of prediabetes and NAFLD increased significantly only in participants with normal BMI. In logistic regression analysis, the odds ratio of prediabetes for NAFLD was 1.85 and those of abdominal obesity for prediabetes and NAFLD was 1.85 and 9.34, respectively. Our results demonstrated that the prevalence of prediabetes and NAFLD was increasing in association with abdominal obesity in Korean children and adolescents.

1 January 2023 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
JSJunghwan Suh
Junghwan Suh
JHJinkyoung Heo
Jinkyoung Heo
SKSujin Kim
Sujin Kim
SPSoyeong Park
Soyeong Park
MJMo Kyung Jung
Mo Kyung Jung
HKHo-Seong Kim
Ho-Seong Kim
Suh J, et al. Yonsei Med J. 2023 Nov;64(11):679-686. https://doi.org/10.3349/ymj.2023.0244

Verified
Journal Article
Open access
PDF file
JSJieun Seo
Jieun Seo
SSSaeam Shin
Saeam Shin
SKSang-Woon Kim
Sang-Woon Kim
SKSu Jin Kim
Su Jin Kim
MLMyeongseob Lee
Myeongseob Lee
AKAhreum Kwon
Ahreum Kwon
The phenotype of the 5α-reductase type 2 deficiency (5αRD2) by the SRD5A2 gene mutation varies, and although there have been many attempts, the genotype-phenotype correlation still has not yet been adequately evaluated. Recently, the crystal structure of the 5α-reductase type 2 isozyme (SRD5A2) has been determined. Therefore, the present study retrospectively evaluated the genotype-phenotype correlation from a structural perspective in 19 Korean patients with 5αRD2. Additionally, variants were classified according to structural categories, and phenotypic severity was compared with previously published data. The p.R227Q variant, which belongs to the NADPH-binding residue mutation category, exhibited a more masculine phenotype (higher external masculinization score) than other variants. Furthermore, compound heterozygous mutations with p.R227Q mitigated phenotypic severity. Similarly, other mutations in this category showed mild to moderate phenotypes. Conversely, the variants categorized as structure-destabilizing and small to bulky residue mutations showed moderate to severe phenotypes, and those categorized as catalytic site and helix-breaking mutations exhibited severe phenotypes. Therefore, the SRD5A2 structural approach suggested that a genotype-phenotype correlation does exist in 5αRD2. Furthermore, the categorization of SRD5A2 gene variants according to the SRD5A2 structure facilitates the prediction of the severity of 5αRD2 and the management and genetic counseling of patients affected by it.